Press

Newsroom

Contact
press@imprimedicine.com
Follow
Download
Press Kit

Featured articles

ImpriMed is Revolutionizing Canine Cancer Treatment with Precision and Personalization
TechCrunch

Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology

Read More →
ImpriMed is Revolutionizing Canine Cancer Treatment with Precision and Personalization
USA Today

ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment

Read More →
ImpriMed is Revolutionizing Canine Cancer Treatment with Precision and Personalization
International Business Times

ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization

Read More →
Meet ImpriMed, Mayo Clinic just welcomed to its AI accelerator program
MedCity News

Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator

Read More →

Latest Stories

Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
Press Releases
BusinessWire

ImpriMed Unveils Cancer Treatment Prediction Technology at EHA-SfPM Meeting, Expands AI-Driven Precision Medicine Services from Pets to Humans

Business Wire
Learn More →
In the News
mobihealthnews logo

ImpriMed unveils cancer treatment forecast technology

MobiHealthNews
Learn More →
In the News
AAHA logo

New research evaluates flow cytometry and PARR as diagnostic support for feline lymphoma

American Animal Hospital Association NEWStat®
Learn More →
Video/Podcast Interviews
Target Cancer Podcast

From Dogs to Humans: The Power of Precision Medicine with Dr. Lim

Target Cancer Podcast
Learn More →
In the News
Veterinary Practice

Cell-sizing method for high-accuracy feline lymphoma characterisation in veterinary sciences

Veterinary Practice
Learn More →
In the News
dvm360 logo

Flow cytometry and clonality evaluation are effective for characterizing feline lymphoma

DVM360
Learn More →
Press Releases
Business Wire Logo

ImpriMed Unveils Groundbreaking Cell-Sizing Method for High-Accuracy Feline Lymphoma Characterization in Veterinary Sciences

Business Wire
Learn More →
Scientific Publications
Veterinary Sciences Logo

Prognostic Utility of the Flow Cytometry and Clonality Analysis Results for Feline Lymphomas

Veterinary Sciences
Learn More →
In the News
Pulse 2.0 Logo

ImpriMed: Providing Personalized Medicine For Pets With Blood Cancer Diseases In A $1+ Billion Market

Pulse 2.0
Learn More →
In the News
Today's Veterinary Business

New AI Tool Guides Canine Cancer Treatment

Today's Veterinary Business
Learn More →
In the News
AVMA News

Artificial intelligence poised to transform veterinary care

AVMA News
Learn More →
In the News
DVM360 logo

New AI service offers personalized drug response predictions for canine patients with cancer

DVM360
Learn More →
Press Releases
BusinessWire Logo

ImpriMed Launches Innovative AI-Driven Drug Response Predictions (DRP) Service to Guide Tailored Treatments, Meet Rising Demand in Veterinary Oncology

Business Wire
Learn More →
Presentations
SAVY Logo

Improving Canine Lymphoma Treatment Outcomes by Individualizing Drug Selection using Machine-Learning-Based Predictive Models

Symposium on Artificial Intelligence in Veterinary Medicine (SAVY)
Learn More →
Press Releases
BusinessWire Logo

ImpriMed to Showcase Groundbreaking AI Research and Applications at Symposium on Artificial Intelligence in Veterinary Medicine (SAVY)

Business Wire
Learn More →
Presentations
WVCC Logo

Treatment-specific risk stratification of feline lymphoma based on unsupervised clustering of flow cytometry results

World Veterinary Cancer Congress 2024
Learn More →
Presentations
WVCC logo

Dramatically increased clinical remission rates and survival times in dogs with high-grade T-cell lymphoma and relapsed B-cell lymphoma in clinical study of AI decision support

World Veterinary Cancer Congress 2024
Learn More →
Press Releases
BusinessWire Logo

ImpriMed to Present Innovative Research at 2024 World Veterinary Cancer Congress

Business Wire
Learn More →